Hester Biosciences Ltd Share Price Today - Hester Biosciences Ltd Stock Price Live NSE/BSE

Hester Biosciences Ltd

NSE: HESTERBIO BSE: 524669

₹1530.10

(-1.11)%

Wed, 11 Feb 2026, 01:00 pm

MTF 5xInvest in Hester Biosciences Ltd with 5x Leverage Buy with MTF

Market Cap13.17B

PE Ratio31.79

Dividend0.45

Health Technology

Pharmaceuticals: Major

24.5K

1 Day

0 (0%)

No Result Found

Summary

Market Cap
1316.56
Net Profit
28.83
P/B
3.39
Sector P/E
32.40
P/E
38.81
EV/EBITDA
18.42
Debt/Equity (Industry)
0.24
Interest Cover (Industry)
12.78
ROCE (Industry)
15.36
RONW (Industry)
13.46
ROE
9.51
ROCE
8.86
Debt/Equity
0.76
EPS (TTM)
48.13
Dividend Yield
0.45
Book Value
397.22
Interest Cover
4.12

Analysis

all

Pros

Dividends per share have increased over the past 10 years.
Dividends paid are well covered by earnings (4.4x coverage).
Hester Biosciences's pays a higher dividend yield than the bottom 25% of dividend payers in India (0.76%).
Hester Biosciences is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
Hester Biosciences is profitable, therefore cash runway is not a concern.

Cons

Dividends per share have been volatile in the past 10 years (annual drop of over 20%).
Hester Biosciences's dividend is below the markets top 25% of dividend payers in India (3.08%).
Hester Biosciences's level of debt (56.5%) compared to net worth is high (greater than 40%).
High level of physical assets or inventory.
Rajiv's remuneration is higher than average for companies of similar size in India.

Financials

Ratios

Shareholders	DEC 2025	SEPT 2025	JUN 2025	MAR 2025	DEC 2024
Promoters	53.73	53.73	53.73	53.73	53.73
FII	0.51	0.53	0.04	0.87	0.59
DII	0.01	0.00	0.02	0.02	0.02
Public	45.75	45.74	46.20	45.38	45.65
Government	0	0	0	0	0

Technical Analysis

RSI

53.10

MACD

-4.06

50 DMA

1547.68

200 DMA

1765.88

Support and Resistance

Type	R1	R2	R3	PP	S1	S2	S3
Classic	2063.43	1779.73	1631.77	1496.03	1348.07	1212.33	928.63
Fibonacci	1779.73	1671.36	1604.41	1496.03	1387.66	1320.71	1212.33
Camarilla	1561.82	1535.81	1509.81	1496.03	1457.79	1431.79	1405.78

Pivots Level: Classic

+567.40

2063.43

+283.70

1779.73

+135.73

1631.77

1496.03

Pivot Point

LTP: 1530.10

-147.97

1348.07

-283.70

1212.33

-567.40

928.63

Moving Average

SMAEMA

Period

Value

10-EMA
1511.85
20-EMA
1507.36
30-EMA
1517.79
50-EMA
1549.99
100-EMA
1628.72
200-EMA
1731.55

Announcement Date	Purpose	Action	Ex Date
30 Jan 2026	board-meetings	Quarterly Results
11 Jul 2025	agm
09 May 2025	dividend	₹7.00 Dividend /Share	06 Aug 2025
26 Jul 2024	agm
10 May 2024	dividend	₹6.00 Dividend /Share	23 Aug 2024
23 Aug 2023	agm
17 May 2023	dividend	₹8.00 Dividend /Share	14 Sept 2023
29 Jul 2022	agm
20 May 2022	dividend	₹10.00 Dividend /Share	12 Aug 2022
23 Jul 2021	agm

Hester Biosciences Ltd

Dr Reddys Laboratories Ltd

Torrent Pharmaceuticals Ltd

Sun Pharmaceutical Industries Ltd

Cipla Ltd

Divis Laboratories Ltd

About Hester Biosciences Ltd

Hester Biosciences is principally engaged in manufacturing of veterinary vaccines and trading of veterinary health products. The Company has two principal operating and reporting segments viz. Poultry healthcare and Animal healthcare.

Industry

Pharmaceuticals - Indian - Formulations

Founded

1987

Headquarters

CEO

Bhupendra V Gandhi

Employees

Contact

Website

http://www.hester.in

investor@hesterbiosciences.co.in

Phone

91-079-26445107

Location

1st Flr PushpakPachvati Circle, Motilal Hirabhai Road, Ahmedabad, Gujarat, 380006

Year	History
2013	Hester Biosciences received WHO GMP Certification. Hester launched Bivalent Marek's Disease Live Vaccine.
2014	Hester Biosciences board approved a scheme of amalgamation. The Company recommended a dividend of Rs. 2.00 per equity share of Rs. 10 each for the financial year 2013-14.
2015	Hester Biosciences launched PPR vaccine and Goat Pox vaccine.
2020	Hester Nepal launched the thermo-tolerant PPR Vaccine.
2021	Hester to produce and commercialize Classical Swine Fever Vaccine and Sheep Pox Vaccine.

Client Name	Order Side	QTY	Avg Price	Date
No Result Found

hester biosciences ltd. News

Hester Biosciences Q3 FY26 Earnings Call Recording

Hester Biosciences makes Q3 FY26 earnings conference call audio recording available on company website following teleconference held on 30 January 2026.

30 Jan 2026

co actions results

Hester Biosciences Q3FY26 Results Call on Jan 30

Hester Biosciences Limited has scheduled an earnings conference call on January 30, 2026, at 2:00 PM IST to discuss Q3FY26 and nine-month financial results with senior management.

23 Jan 2026

co actions results

Hester Biosciences Appoints Ashish Desai as CFO and Updates KMP Authorization

Hester Biosciences' Board of Directors approved the appointment of Ashish Desai as Chief Financial Officer and Key Managerial Personnel, leading to changes in authorized KMPs for material disclosure determinations. The company updated its contact details for regulatory compliance under SEBI listing regulations, with Vinod Mali serving as the single point of contact for disclosure requirements.

20 Nov 2025

corporate governance

Hester Biosciences Reports Mixed Q2/H1 FY26 Results with 13% Revenue Decline in India Business

Hester Biosciences reported standalone sales of INR 64 crores in Q2 and INR 128 crores in H1 FY26, marking declines of 12% and 13% respectively, with EBITDA and net profit falling 13% and 15% for the half-year period. The company's Poultry Healthcare division showed growth of 18% in Q2 and 10% in H1, while Animal Healthcare declined 50% in Q2 due to delays in government immunization programs, though management expects improved performance in the second half driven by new facility capitalization and H9N2 vaccine commercialization.

14 Nov 2025

earnings

Hester Biosciences CFO Divyesh Maru Resigns to Pursue Other Career Interests

Divyesh Maru has resigned from his position as Chief Financial Officer and Key Managerial Personnel at Hester Biosciences Limited, effective from the close of office hours on 13 November 2025. The resignation was submitted to pursue other career interests, with the company acknowledging his contributions during his tenure as CFO.

13 Nov 2025

corporate governance

Showing 1–5 of 15

Rows per page:

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800